Overview

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Hypersalivation (Too much saliva) and drooling is a side effect experienced by 31% of people taking the antipsychotic clozapine. This study aims to determine if using the medication ipratropium bromide(IPB)at bedtime will reduce the amount of salivation and the distress people may feel.
Phase:
N/A
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Treatments:
Bromides
Clozapine
Ipratropium